Mihic-Probst D - Search Results

1

Immunostaining for the tumour suppressor gene p16 product is a useful marker to differentiate melanoma metastasis from lymph-node nevus.

Mihic-Probst D, Saremaslani P, Komminoth P, Heitz PU. Mihic-Probst D, et al. Virchows Arch. 2003 Dec;443(6):745-51. doi: 10.1007/s00428-003-0897-9. Epub 2003 Oct 24. Virchows Arch. 2003. PMID: 14576937

2

Spitzoid malignant melanoma with lymph-node metastasis. Is a copy-number loss on chromosome 6q a marker of malignancy?

Mihic-Probst D, Zhao J, Saremaslani P, Baer A, Komminoth P, Heitz PU. Mihic-Probst D, et al. Virchows Arch. 2001 Dec;439(6):823-6. doi: 10.1007/s004280100517. Virchows Arch. 2001. PMID: 11787857

3

CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma.

Mihic-Probst D, Zhao J, Saremaslani P, Baer A, Oehlschlegel C, Paredes B, Komminoth P, Heitz PU. Mihic-Probst D, et al. Anticancer Res. 2004 Jan-Feb;24(1):19-26. Anticancer Res. 2004. PMID: 15015571 Free article.

4

Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.

Mihic-Probst D, Perren A, Schmid S, Saremaslani P, Komminoth P, Heitz PU. Mihic-Probst D, et al. Anticancer Res. 2004 Jul-Aug;24(4):2415-8. Anticancer Res. 2004. PMID: 15330192 Free article.

5

p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.

Mihic-Probst D, Mnich CD, Oberholzer PA, Seifert B, Sasse B, Moch H, Dummer R. Mihic-Probst D, et al. Int J Cancer. 2006 May 1;118(9):2262-8. doi: 10.1002/ijc.21608. Int J Cancer. 2006. PMID: 16331607

6

Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.

Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, Storz M, Seifert B, Marino S, Schraml P, Dummer R, Moch H. Mihic-Probst D, et al. Int J Cancer. 2007 Oct 15;121(8):1764-70. doi: 10.1002/ijc.22891. Int J Cancer. 2007. PMID: 17597110

7

Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.

Curioni-Fontecedro A, Nuber N, Mihic-Probst D, Seifert B, Soldini D, Dummer R, Knuth A, van den Broek M, Moch H. Curioni-Fontecedro A, et al. PLoS One. 2011;6(6):e21418. doi: 10.1371/journal.pone.0021418. Epub 2011 Jun 27. PLoS One. 2011. PMID: 21738656 Free PMC article.

8

[Insights into melanoma from a pathologist's perspective].

Mihic-Probst D, Beer M. Mihic-Probst D, et al. Praxis (Bern 1994). 2013 Feb 13;102(4):219-24. doi: 10.1024/1661-8157/a001190. Praxis (Bern 1994). 2013. PMID: 23399605 Review. German.

9

New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation.

Rupp NJ, Rechsteiner M, Freiberger SN, Lenggenhager D, Urosevic M, Burger IA, Rushing EJ, Mihic-Probst D. Rupp NJ, et al. Virchows Arch. 2018 Oct;473(4):517-521. doi: 10.1007/s00428-018-2376-3. Epub 2018 May 21. Virchows Arch. 2018. PMID: 29785541

10

The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma--a retrospective analysis of 392 cases.

Guggenheim M, Dummer R, Jung FJ, Mihic-Probst D, Steinert H, Rousson V, French LE, Giovanoli P. Guggenheim M, et al. Br J Cancer. 2008 Jun 17;98(12):1922-8. doi: 10.1038/sj.bjc.6604407. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18506141 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters